TRANSCEND-T2D-1 full publication, The Lancet , June 2026 Giblin K et al
Dose-Dependent GI Side Effects Studies show that gastrointestinal side effects are most frequent and intense during the early stages of GLP-1 receptor agonist therapy and are largely dose-dependent. This isnt a sign that the medication is harming the body
7 Conclusion and Future Directions This review aims to provide an overview and update on the pathogenesis, reported precipitating factors, genetic risk factors, presentation, diagnosis, and management of SJS/TEN
Walcobal Injection is used to manage vitamin B12 deficiency anaemia and neuropathy, conditions that might develop due to inadequate dietary intake, certain medications, or other medical conditions
Figutumumab has also been tested in phase I (NCT00635245 and NCT01536145) and phase II (NCT00372996) clinical trials against BrCa with apparently negative unpublished results
Dysregulated expression or function of SRs has been implicated in the breakdown of self-tolerance and chronic inflammation, hallmarks of SLE pathogenesis